bioaccess® is the clinical research CRO in El Salvador for first-in-human device work: Miami headquarters, in-country operations, and the SRS/CNEIS file — with the honest 3–5 month clock and the ISO 14155 inspection bar. We run trials there.
bioaccess® is the CRO in El Salvador and CRO en El Salvador for first-in-human device work. Miami headquarters. The Superintendencia de Regulación Sanitaria (SRS) — autonomous since August 2024 — and the Comité Nacional de Ética de la Investigación en Salud (CNEIS) are the authorities on the file. A CRO that quotes you 30–60 day startup in El Salvador is selling you a delay; the realistic submission-to-first-patient envelope is 3–5 months, with device import as a separate SRS step.